Metropolitan Life Insurance Company (MetLife)’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-141,155
| Closed | -$14M | – | 2623 |
|
|
2019
Q3 | $14M | Buy |
141,155
+879
| +0.6% | +$83.5K | 0.24% | 74 |
|
|
2019
Q2 | $13M | Buy |
140,276
+6,592
| +5% | +$626K | 0.22% | 82 |
|
|
2019
Q1 | $12.6M | Sell |
133,684
-3,890
| -3% | -$340K | 0.23% | 79 |
|
|
2018
Q4 | $8.82M | Sell |
137,574
-87
| -0.1% | -$6.42K | 0.18% | 96 |
|
|
2018
Q3 | $12.3M | Sell |
137,661
-5,297
| -4% | -$468K | 0.21% | 83 |
|
|
2018
Q2 | $11.4M | Sell |
142,958
-6,234
| -4% | -$518K | 0.18% | 97 |
|
|
2018
Q1 | $13.3M | Sell |
149,192
-5,782
| -4% | -$555K | 0.19% | 81 |
|
|
2017
Q4 | $16.2M | Sell |
154,974
-249,158
| -62% | -$28.1M | 0.21% | 71 |
|
|
2017
Q3 | $58.9M | Sell |
404,132
-4,481
| -1% | -$610K | 0.37% | 48 |
|
|
2017
Q2 | $53.1M | Sell |
408,613
-5,152
| -1% | -$631K | 0.37% | 48 |
|
|
2017
Q1 | $51.5M | Sell |
413,765
-4,396
| -1% | -$526K | 0.36% | 49 |
|
|
2016
Q4 | $48.4M | Sell |
418,161
-11,654
| -3% | -$1.3M | 0.35% | 50 |
|
|
2016
Q3 | $44.9M | Sell |
429,815
-5,088
| -1% | -$551K | 0.33% | 51 |
|
|
2016
Q2 | $42.9M | Sell |
434,903
-9,293
| -2% | -$961K | 0.32% | 54 |
|
|
2016
Q1 | $44.5M | Sell |
444,196
-7,966
| -2% | -$820K | 0.34% | 54 |
|
|
2015
Q4 | $54.2M | Sell |
452,162
-8,000
| -2% | -$926K | 0.42% | 43 |
|
|
2015
Q3 | $49.8M | Sell |
460,162
-9,241
| -2% | -$1.15M | 0.36% | 49 |
|
|
2015
Q2 | $54.3M | Sell |
469,403
-1,064
| -0.2% | -$122K | 0.38% | 47 |
|
|
2015
Q1 | $54.2M | Sell |
470,467
-4,896
| -1% | -$585K | 0.4% | 50 |
|
|
2014
Q4 | $53.2M | Sell |
475,363
-2,102
| -0.4% | -$222K | 0.37% | 52 |
|
|
2014
Q3 | $45.3M | Sell |
477,465
-8,421
| -2% | -$760K | 0.33% | 56 |
|
|
2014
Q2 | $41.7M | Sell |
485,886
-31,120
| -6% | -$2.37M | 0.29% | 63 |
|
|
2014
Q1 | $36.1M | Sell |
517,006
-14,922
| -3% | -$1.18M | 0.25% | 80 |
|
|
2013
Q4 | $44.9M | Sell |
531,928
-9,352
| -2% | -$740K | 0.32% | 61 |
|
|
2013
Q3 | $41.7M | Sell |
541,280
-11,266
| -2% | -$790K | 0.32% | 61 |
|
|
2013
Q2 | $32.3M | Buy |
+552,546
| New | +$33.3M | 0.26% | 77 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Metropolitan Life Insurance Company (MetLife)'s CELG Position: Q4 2019 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 141,155 shares — an estimated $14M sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $58.9M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 141,155 Celgene Corp shares in Q4 2019, an estimated $14M.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Celgene Corp position peaked at $58.9M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2019, filed 14 Feb 2020.